Delhi HC restores ban on diabetes FDC drugs

The Delhi High Court has restored the prohibition on two fixed-dose combination (FDC) drugs prescribed for Type-II diabetes, overturning a previous single judge's order and ruling that the Centre acted within its statutory mandate to safeguard public health while imposing the ban.

- BHAVINI MISHRA

The ban dates back to twin notifications issued by the Centre in 2018, which prohibited the manufacture and sale of formulations combining glimepiride, pioglitazone, and metformin in specified strengths. Those notifications had earlier been set aside by a single judge, prompting an appeal by the Union government.